Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Interventional, Open-label, Trial Investigating the Safety, Tolerability, and Pharmacokinetic Properties of Lu AF28996 in Chinese Men and Women With Parkinson's Disease

NCT07513441 is registered in ClinicalTrials.gov with H. Lundbeck A/S as lead sponsor.

NCT NCT07513441
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07513441 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Interventional, Open-label, Trial Investigating the Safety, Tolerability, and Pharmacokinetic Properties of Lu AF28996 in Chinese Men and Women With Parkinson's Disease
Lead sponsor
H. Lundbeck A/S
Phase
Phase 1
Overall status
Recruiting
Start date
May 26, 2026
Completion date
May 31, 2027
Enrollment
10 (estimated)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

parkinson disease